Previously, we have shown an altered expression of different adipocytokines (leptin, adiponectin, resistin) both at circulating level and increased tissue expression in pathologies characterized by an increased cardiovascular risk (i.e., Primary Aldosteronism and Subclinical Cushing's Syndrome) (31, 32). The gene discussed is ADIPOQ; the disease is primary aldosteronism.